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Figure*11.**Fluorescence*ratio*vs*time*for*
Resveratrol*at*A)*5*μM*B)*10*μM*C)*20*μM*and*
D)*50*μM*
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Rifampicin))
Figures"12"A,D"show"the"plot"of"the"fluorescence"ratios"versus"time"for"samples"containing"Rifampicin"as"
well"as"for"the"controls.""It"was"first"observed"that"both"the"IAPP"control"and"the"IAPP"+"Rifampicin"
samples"had"a"higher"fluorescence"signal"ratio"than"the"lipid"control,"which"alludes"to"the"formation"of"
IAPP"fibrils"in"both"of"these"samples.""It"was"also"observed"that"all"the"IAPP"+"Rifampicin"samples"had"less"
fluorescence"upon"the"insertion"of"the"IAPP"peptides"than"the"IAPP"control,"with"the"5"μM"sample"
fluorescence"signal"reduced"by"approximately"30%,"the"10"μM"sample"reduced"by"approximately"42%,"
the"20"μM"sample"reduced"by"approximately""56%"and"50"μM"both"reduced"by"approximately"46%."""
This"suggests"that"Rifampicin"prevents"IAPP"fibrils"from"forming"and"penetrating"the"cell"membrane"with"
a"possible"maximum"reduction"potential.""
"
"It"is"unclear"why"the"fluorescence"ratio"of"the"20"μM"and"50"μM"samples"increased"from"the"5"μM"and"
10"μM"samples.""A"possible"explanation"would"be"premature"IAPP"fibril"formation"during"the"process"of"
preparing"the"assay"before"the"30"hour"observation"period"began,"thus"raising"the"initial"observed"
fluorescence"for"this"period."""The"2"spikes"observed"during"the"30"hour"observation"period"for"the"20"
μM"sample"could"also"be"evidence"of"fibril"formation"despite"the"presence"of"Rifampicin."""Since"the"
increase"(almost"100%"at"the"maximum"fluorescence"before"detergent"was"added)"is"large"enough"to"be"
considered"of"statistical"significance,"it"is"unclear"if"there"is"a"maximum"reduction"potential"for"
Rifampicin."""The"Rifampicin"control"samples"had"very"similar"fluorescence"profiles"to"the"lipid"control"
which"suggests"that"Rifampicin"does"not"have"any"membrane"disrupting"properties"in"isolation."
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Figure)12.))Fluorescence)ratio)vs)time)for)
Rifampicin)at)A))5)μM)B))10)μM)C))20)μM)and)
D))50)μM"
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Conclusion)
Each#of#the#five#constituents#studied#appear#to#inhibit#IAPP#fibril#formation#with#varying##
mechanisms#and#degrees#of#effectiveness.##As#the#prevalence#of#Type#II#diabetes#continues#to##
be#an#epidemic#in#this#country,#it#is#imperative#that#the#medical#research#community#determine#
effective#methods#of#treatment#and#prevention.##In#theory,#these#compounds#have#the#
potential#to#help#alleviate#the#processes#that#lead#to#development#of#this#disease.##However,#it#
is#also#clear#that#an#inhibition#of#fibril#formation#does#not#necessarily#correlate#with#a#decrease#
in#βB#cell#death#and#toxicity.##Further#studies#should#be#taken#to#investigate#the#relationship#
between#these#compounds#and#the#prevalence#of#disease.##If#such#a#life#threatening#disease#
could#be#significantly#prevented#with#simple#changes#in#diet#without#the#potential#additional#
toxicity#of#medical#intervention,#a#gradual#decline#in#disease#rates#for#Type#II#diabetes,#heart#
disease#and#stroke#may#be#possible#in#the#near#future.#######
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